Most recently, Dr Solomon served as COO of Vital Sensors. Dr Solomon studied medicine and received his doctorate at Cornell University Medical College and the Sloan-Kettering division of its Graduate School of Medical Sciences, in New York City.
Daan Ellens, chairman of Zealand Pharma, said: “We are delighted to have David as the new CEO. He brings more than 20 years of experience in medical research, healthcare investing and key biopharmaceutical and medical device operating roles.
“His senior management experience, commercial and clinical development knowledge and investing background will be extremely valuable to the organization as the company moves forward.”